Holmen SL - Search Results

1

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.

Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT. Ray A, et al. Among authors: holmen sl. Oncotarget. 2016 Sep 27;7(39):64390-64399. doi: 10.18632/oncotarget.10453. Oncotarget. 2016. PMID: 27391442 Free PMC article. Clinical Trial.

2

Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma.

VanBrocklin MW, Verhaegen M, Soengas MS, Holmen SL. VanBrocklin MW, et al. Among authors: holmen sl. Cancer Res. 2009 Mar 1;69(5):1985-94. doi: 10.1158/0008-5472.CAN-08-3934. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244105 Free PMC article.

3

Met amplification and tumor progression in Cdkn2a-deficient melanocytes.

Vanbrocklin MW, Robinson JP, Whitwam T, Guilbeault AR, Koeman J, Swiatek PJ, Vande Woude GF, Khoury JD, Holmen SL. Vanbrocklin MW, et al. Among authors: holmen sl. Pigment Cell Melanoma Res. 2009 Aug;22(4):454-60. doi: 10.1111/j.1755-148X.2009.00576.x. Epub 2009 Apr 29. Pigment Cell Melanoma Res. 2009. PMID: 19422607 Free PMC article.

4

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.

Robinson JP, VanBrocklin MW, Guilbeault AR, Signorelli DL, Brandner S, Holmen SL. Robinson JP, et al. Among authors: holmen sl. Oncogene. 2010 Jan 21;29(3):335-44. doi: 10.1038/onc.2009.333. Epub 2009 Oct 26. Oncogene. 2010. PMID: 19855433 Free PMC article.

5

Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.

VanBrocklin MW, Robinson JP, Lastwika KJ, Khoury JD, Holmen SL. VanBrocklin MW, et al. Among authors: holmen sl. Pigment Cell Melanoma Res. 2010 Aug;23(4):531-41. doi: 10.1111/j.1755-148X.2010.00717.x. Epub 2010 Apr 23. Pigment Cell Melanoma Res. 2010. PMID: 20444198 Free PMC article.

6

Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.

Robinson JP, Vanbrocklin MW, Lastwika KJ, McKinney AJ, Brandner S, Holmen SL. Robinson JP, et al. Among authors: holmen sl. Oncogene. 2011 Mar 17;30(11):1341-50. doi: 10.1038/onc.2010.513. Epub 2010 Nov 8. Oncogene. 2011. PMID: 21057530 Free PMC article.

7

Akt signaling is required for glioblastoma maintenance in vivo.

Robinson JP, Vanbrocklin MW, McKinney AJ, Gach HM, Holmen SL. Robinson JP, et al. Among authors: holmen sl. Am J Cancer Res. 2011;1(2):155-167. Am J Cancer Res. 2011. PMID: 21796274 Free PMC article.

8

Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.

Vanbrocklin MW, Robinson JP, Lastwika KJ, McKinney AJ, Gach HM, Holmen SL. Vanbrocklin MW, et al. Among authors: holmen sl. Neuro Oncol. 2012 Jan;14(1):34-42. doi: 10.1093/neuonc/nor184. Epub 2011 Oct 20. Neuro Oncol. 2012. PMID: 22015595 Free PMC article.

9

Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions.

Jenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D. Jenkins NC, et al. Among authors: holmen sl. J Invest Dermatol. 2013 Apr;133(4):1043-51. doi: 10.1038/jid.2012.401. Epub 2012 Nov 29. J Invest Dermatol. 2013. PMID: 23190892 Free PMC article.

10

Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss.

Robinson GL, Robinson JP, Lastwika KJ, Holmen SL, Vanbrocklin MW. Robinson GL, et al. Among authors: holmen sl. Genes Cancer. 2013 Nov;4(11-12):476-85. doi: 10.1177/1947601913513268. Genes Cancer. 2013. PMID: 24386508 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters